chr2-44201680-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002706.6(PPM1B):āc.481C>Gā(p.Gln161Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000508 in 1,614,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_002706.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPM1B | NM_002706.6 | c.481C>G | p.Gln161Glu | missense_variant | 2/6 | ENST00000282412.9 | NP_002697.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPM1B | ENST00000282412.9 | c.481C>G | p.Gln161Glu | missense_variant | 2/6 | 1 | NM_002706.6 | ENSP00000282412.4 | ||
ENSG00000285542 | ENST00000649044.1 | n.481C>G | non_coding_transcript_exon_variant | 2/15 | ENSP00000497083.1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152168Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251298Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135800
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727242
GnomAD4 genome AF: 0.000282 AC: 43AN: 152286Hom.: 1 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 08, 2019 | The p.Gln161Glu variant (rs34745955) has not been reported in the medical literature, is not listed in gene-specific variant databases, nor has it been previously identified in our laboratory. It is listed in the NHLBI GO Exome Sequencing Project (ESP) with an overall allele frequency of 0.07% (identified in 9 out of 13,006 chromosomes), and in the Exome Aggregation Consortium (ExAC) browser with an overall frequency of 0.006% (identified in 7 out of 121,394 chromosomes). The glutamine at codon 161 is moderately conserved considering 13 species (Alamut software v2.8.1), and computational analyses return mixed results regarding the effect of this variant on PPM1B protein structure/function (SIFT: tolerated, PolyPhen2: benign, and Mutation Taster: disease causing). Thus, based on the available information, the clinical significance of the p.Gln161Glu variant cannot be determined with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.481C>G (p.Q161E) alteration is located in exon 2 (coding exon 1) of the PPM1B gene. This alteration results from a C to G substitution at nucleotide position 481, causing the glutamine (Q) at amino acid position 161 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at